Banka BioLoo (BANKA)₹87.47+2.34%Civil Construction
In the Jun 2026 quarter (consolidated), Banka BioLoo reported sales of ₹10.58 Cr, down 5.5% from Jun 2025, and net profit of −₹0.03 Cr. For the year to Mar 2026, sales were ₹57.35 Cr and net profit ₹0.38 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 11.50 | 14.01 | 16.37 | 12.95 | 12.46 | 14.10 | 14.89 | 11.19 | 13.06 | 15.33 | 17.75 | 10.58 |
| Expenses | 9.19 | 12.22 | 15.32 | 11.19 | 16.95 | 14.04 | 15.06 | 10.84 | 13.06 | 13.83 | 14.36 | 8.77 |
| Operating Profit | 2.28 | 1.77 | 1.02 | 1.73 | −4.47 | 0.02 | −0.16 | 0.33 | 0.00 | 1.46 | 3.35 | 1.80 |
| OPM % | 20.0% | 12.7% | 6.3% | 13.5% | −36.1% | 0.2% | −1.2% | 3.0% | −0.1% | 9.6% | 19.0% | 17.1% |
| Other Income | 0.09 | 0.10 | 0.11 | 0.11 | −0.22 | 0.11 | 0.02 | 1.05 | 0.06 | 0.06 | −0.15 | 0.10 |
| Interest | 0.67 | 0.64 | 0.62 | 0.86 | 0.84 | 1.00 | 1.02 | 0.88 | 0.92 | 0.90 | 0.92 | 1.15 |
| Depreciation | 0.54 | 0.56 | 0.60 | 0.61 | 0.61 | 0.62 | 0.65 | 0.63 | 0.69 | 0.76 | 0.68 | 0.84 |
| Profit before tax | 1.17 | 0.68 | −0.10 | 0.38 | −6.19 | −1.50 | −1.84 | −0.14 | −1.58 | −0.15 | 1.59 | −0.10 |
| Tax % | −5.2% | −3.0% | 166.7% | 21.7% | −0.8% | −2.0% | −12.0% | −99.9% | −30.5% | −14.2% | −1.9% | −55.5% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 1.21 | 0.68 | −0.24 | 0.28 | −6.12 | −1.45 | −1.60 | 0.00 | −1.07 | −0.12 | 1.59 | −0.03 |
| EPS (Rs) | 1.13 | 0.66 | −0.23 | 0.28 | −5.67 | −1.36 | −1.50 | 0.02 | −1.00 | −0.15 | 1.46 | −0.02 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|
| Sales | 48.05 | 30.60 | 38.89 | 42.49 | 50.20 | 54.36 | 57.35 | 56.72 |
| Expenses | 39.28 | 27.10 | 33.31 | 36.25 | 46.32 | 57.23 | 52.08 | 50.02 |
| Operating Profit | 8.67 | 3.44 | 5.54 | 6.18 | 3.79 | −2.84 | 5.20 | 6.61 |
| OPM % | 18.2% | 11.3% | 14.3% | 14.6% | 7.6% | −5.3% | 9.1% | 11.7% |
| Other Income | 0.44 | 0.57 | 0.47 | 0.70 | 0.48 | 0.04 | 1.01 | 0.07 |
| Interest | 0.82 | 1.55 | 1.78 | 1.78 | 2.65 | 3.78 | 3.68 | 3.89 |
| Depreciation | 0.46 | 0.59 | 0.93 | 1.47 | 2.18 | 2.52 | 2.79 | 2.97 |
| Profit before tax | 7.85 | 1.88 | 3.32 | 3.64 | −0.57 | −9.13 | −0.27 | −0.24 |
| Tax % | 20.7% | −17.6% | 6.1% | 30.1% | 19.7% | −2.4% | −253.8% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 6.21 | 2.19 | 3.10 | 2.53 | −0.66 | −8.90 | 0.38 | 0.37 |
| EPS (Rs) | 6.07 | 2.15 | 2.88 | 2.35 | −0.61 | −8.23 | 0.33 | 0.29 |
| Dividend payout % | 6.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 4.09 | 10.23 | 10.80 | 10.81 | 10.81 | 10.83 | 10.88 |
| Reserves | 23.84 | 19.69 | 26.62 | 29.24 | 28.90 | 20.62 | 28.67 |
| Borrowings | 11.40 | 11.65 | 18.45 | 16.67 | 25.87 | 34.66 | 40.73 |
| Other Liabilities | 7.27 | 4.62 | 8.00 | 8.35 | 11.76 | 15.85 | 20.28 |
| Total Liabilities | 46.60 | 46.19 | 63.87 | 65.07 | 77.34 | 81.96 | 101 |
| Fixed Assets | 4.03 | 5.11 | 6.80 | 10.72 | 15.46 | 15.91 | 27.84 |
| CWIP | 0.00 | 0.00 | 2.43 | 3.44 | 6.54 | 7.67 | 0.49 |
| Investments | 0.00 | 0.01 | 0.04 | 0.05 | 0.01 | 0.03 | 0.06 |
| Other Assets | 42.57 | 41.07 | 54.60 | 50.86 | 55.33 | 58.35 | 72.17 |
| Inventories | 3.77 | 8.04 | 8.40 | 8.73 | 8.27 | 5.81 | 6.11 |
| Trade receivables | 14.98 | 11.69 | 20.37 | 22.91 | 22.95 | 27.79 | 29.14 |
| Cash & equivalents | 4.34 | 6.51 | 4.30 | 2.60 | 2.70 | 4.67 | 11.05 |
| Total Assets | 46.60 | 46.19 | 63.87 | 65.07 | 77.34 | 81.96 | 101 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | −5.57 | 5.87 | −0.45 | 7.36 | 2.77 | 0.88 | 1.06 |
| Cash from investing activity | −5.05 | −4.69 | −6.67 | −7.45 | −11.79 | −6.01 | −2.15 |
| Cash from financing activity | 7.17 | −3.70 | 0.96 | −3.34 | 6.79 | 5.09 | 11.09 |
| Net cash flow | −3.46 | −2.51 | −6.13 | −3.43 | −2.27 | −0.06 | 9.94 |
| Capex | 1.40 | 0.50 | 3.15 | 6.40 | 9.94 | 4.47 | 5.99 |
| Free cash flow | −6.94 | 5.33 | −3.58 | 0.93 | −7.18 | −3.56 | −4.93 |
| CFO / OP % | −80.1% | 134.9% | 4.0% | 131.9% | 92.9% | −66.1% | 19.9% |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor days | 113 | 139 | 191 | 197 | 167 | 186 | 185 |
| Inventory days | — | — | 456 | 575 | 186 | — | 159 |
| Days payable | — | — | 200 | 209 | 89 | — | 209 |
| Cash conversion cycle | 114 | 140 | 449 | 565 | 265 | 187 | 138 |
| Working capital days | 149 | 244 | 246 | 177 | 155 | 72 | 88 |
| ROCE % | — | 8.5% | 10.5% | 9.6% | 3.5% | −7.6% | 5.0% |
For the Jun 2026 quarter, Banka BioLoo reported sales of ₹10.58 Cr, down 5.5% year on year and net profit of −₹0.03 Cr. The operating margin was 17.1%.
Banka BioLoo's sales for the year to Mar 2026 were ₹57.35 Cr; over the last twelve months they were ₹56.72 Cr.
Net profit for the year to Mar 2026 was ₹0.38 Cr, and ₹0.37 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.29.
Banka BioLoo reported borrowings of ₹40.73 Cr at Mar 2026, against cash and equivalents of ₹11.05 Cr.
Cash from operations was ₹1.06 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹4.93 Cr.